Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMRT Combined With S-1 Capsule vs Cisplatin + 5-FU in Nasopharyngeal Carcinoma
ChiCTR-IPR-16008835Phase 4Recruiting
- Sponsor
- Navy General Hospital
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tegafur, cisplatin and fluorouracil in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Navy General Hospital. Primary endpoints: progression-free survival and overall survival. Started Jul 2016; status: recruiting.
02
Drugs
tegafurcisplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-IPR-16008835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008835.